Get startedLog in
    Picture of Obsidian Therapeutics logo

    OBX — Obsidian Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Galera Announces First Patient Dosed With GC4711 In Phase 2B Greco-2 Trial In Patients With Pancreatic Cancer

    Picture of Obsidian Therapeutics logoObsidian Therapeutics
    17/05/2021 12:12
    May 17 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA ANNOUNCES FIRST PATIENT DOSED WITH GC4711 IN PHASE
2B
GRECO-2 TRIAL IN PATIENTS WITH PANCREATIC CANCER

Source text for Eikon:  ID:nGNXbdLT3m 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Obsidian Therapeutics

    See all news